ASH 2016 Annual Meeting Highlights In Multiple Myeloma: Minimal Residual Disease and Biomarkers - 100065

Spotlight
Video

ASH 2016 Annual Meeting Highlights In Multiple Myeloma: Minimal Residual Disease and Biomarkers

Loading........
Description: Presented by Paul G. Richardson, MD.

Health care providers, especially community-based practitioners, are challenged with attending major medical conferences, learning about new data, and understanding their relevance and potential impact on clinical practice. In this activity, participants will learn about key highlights of the most impactful and groundbreaking data in multiple myeloma (MM), presented at the 2016 American Society of Hematology (ASH) annual meeting.

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Celgene Corporation and Takeda Oncology.
Shared By : managingmyeloma
Posted on : 02/24/17
Added : 12 months ago
Category : Multiple Myeloma



More From managingmyeloma

Nothing found.